About: Neurotech International Limited, a clinical-stage biopharmaceutical development company, focuses on development of solutions for paediatric neurological disorders with a broad-spectrum oral cannabinoid drug therapy in Australia. The company develops NTI164 to treat autism spectrum disorder, paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections, paediatric acute-onset neuropsychiatric syndrome, and Rett syndrome. It also engages in executing medical research projects; and developing technological devices. The company conducts clinical studies to assess the neuro-protective, anti-inflammatory, and neuro-modulatory activities of its proprietary cannabis strains. The company has a collaboration with The University of Sydney. Neurotech International Limited was incorporated in 2016 and is based in Melbourne, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.01 (-7.14%)
NTI ASX Neurotech International Ltd
Neurotech International Ltd share price
NTI price activity
Last Price
$0.010
Change (24hr)
-0.00 AUD (-7.14%)
Volume
952.78K
Volume (4w avg)
-
Open
$0.01
Day Range
$0.01 - $0.01
Previous Close
$0.01
Last Trade
09 Oct, 5:10 am GMT+0
Delayed
09 Oct, 5:10 am GMT+0
NTI price performance
Delayed
09 Oct, 5:10 am GMT+0
NTI Market Signals